Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Fabio Morandi, Sarah Pozzi, Sebastiano Barco, Giuliana Cangemi, Loredana Amoroso, Barbara Carlini, Vito Pistoia & Maria Valeria Corrias. (2016) CD4+CD25hiCD127− Treg and CD4+CD45R0+CD49b+LAG3+ Tr1 cells in bone marrow and peripheral blood samples from children with neuroblastoma. OncoImmunology 5:12.
Read now
Read now
Vijayamurugan Nataraj, Nitin Mathur, Lata Rani, Ritu Gupta & Sameer Bakhshi. (2016) Serial assessment of circulating T regulatory cells and T helper 17 cells in pediatric non-Hodgkin lymphoma: a prospective study. Leukemia & Lymphoma 57:7, pages 1739-1742.
Read now
Read now
Articles from other publishers (17)
Seiichiro Inoue, Yuta Takeuchi, Yutaka Horiuchi, Takashi Murakami & Akio Odaka. (2023) CD69 on Tumor-Infiltrating Cells Correlates With Neuroblastoma Suppression by Simultaneous PD-1 and PD-L1 Blockade. Journal of Surgical Research 289, pages 190-201.
Crossref
Crossref
Zoriamin Rivera, Carlos Escutia, Mary Beth Madonna & Kajal H. Gupta. (2023) Biological Insight and Recent Advancement in the Treatment of Neuroblastoma. International Journal of Molecular Sciences 24:10, pages 8470.
Crossref
Crossref
Christine Weißenborn, Sophie von Lenthe, Nicole Hinz, Stefanie Langwisch, Mandy Busse, Anne Schumacher, Ana C. Zenclussen & Stefan Fest. (2022)
Depletion of Foxp3+ regulatory T cells but not the absence of
CD19
+
IL
‐10+ regulatory B cells hinders tumor growth in a para‐orthotopic neuroblastoma mouse model
. International Journal of Cancer 151:11, pages 2031-2042.
Crossref
Crossref
Reza Bayat Mokhtari, Manpreet Sambi, Bessi Qorri, Narges Baluch, Neda Ashayeri, Sushil Kumar, Hai-Ling Margaret Cheng, Herman Yeger, Bikul Das & Myron R. Szewczuk. (2021) The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy. Cancers 13:14, pages 3596.
Crossref
Crossref
Judith Wienke, Miranda P. Dierselhuis, Godelieve A.M. Tytgat, Annette Künkele, Stefan Nierkens & Jan J. Molenaar. (2021) The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology. European Journal of Cancer 144, pages 123-150.
Crossref
Crossref
Izhar S. Batth, Long Dao, Arun Satelli, Abhisek Mitra, Sofia Yi, Hyangsoon Noh, Heming Li, Zachary Brownlee, Shouhao Zhou, Jeffrey Bond, Jing Wang, Jonathan Gill, Giselle S. Sholler & Shulin Li. (2020) Cell surface vimentin‐positive circulating tumor cell‐based relapse prediction in a long‐term longitudinal study of postremission neuroblastoma patients. International Journal of Cancer 147:12, pages 3550-3559.
Crossref
Crossref
Kevin X. Liu & Shweta Joshi. (2020) “Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma. Frontiers in Immunology 11.
Crossref
Crossref
Shweta Joshi. (2020) Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions. Cancers 12:8, pages 2057.
Crossref
Crossref
Celina L. Szanto, Annelisa M. Cornel, Saskia V. Vijver & Stefan Nierkens. (2020) Monitoring Immune Responses in Neuroblastoma Patients during Therapy. Cancers 12:2, pages 519.
Crossref
Crossref
L.L. Stafman, J. Aye & E.A. Beierle. 2019. Neuroblastoma. Neuroblastoma
187
202
.
Thitinee Vanichapol, Wararat Chiangjong, Jirawan Panachan, Usanarat Anurathapan, Somchai Chutipongtanate & Suradej Hongeng. (2018)
Secretory High-Mobility Group Box 1 Protein Affects Regulatory T Cell Differentiation in Neuroblastoma Microenvironment
In Vitro
. Journal of Oncology 2018, pages 1-12.
Crossref
Crossref
Samuel S. Duffy, Brooke A. Keating, Chamini J. Perera & Gila Moalem-Taylor. (2018) The role of regulatory T cells in nervous system pathologies. Journal of Neuroscience Research 96:6, pages 951-968.
Crossref
Crossref
Thitinee Vanichapol, Somchai Chutipongtanate, Usanarat Anurathapan & Suradej Hongeng. (2018) Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma. BioMed Research International 2018, pages 1-11.
Crossref
Crossref
Valentina Rigo, Laura Emionite, Antonio Daga, Simonetta Astigiano, Maria Valeria Corrias, Concetta Quintarelli, Franco Locatelli, Silvano Ferrini & Michela Croce. (2017) Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma. Scientific Reports 7:1.
Crossref
Crossref
Michela Croce, Maria Valeria Corrias, Valentina Rigo & Silvano Ferrini. (2015) New immunotherapeutic strategies for the treatment of neuroblastoma. Immunotherapy 7:3, pages 285-300.
Crossref
Crossref
Fabio Morandi, Michela Croce, Giuliana Cangemi, Sebastiano Barco, Valentina Rigo, Barbara Carlini, Loredana Amoroso, Vito Pistoia, Silvano Ferrini & Maria Valeria Corrias. (2015) IL-10 and ARG-1 Concentrations in Bone Marrow and Peripheral Blood of Metastatic Neuroblastoma Patients Do Not Associate with Clinical Outcome. Journal of Immunology Research 2015, pages 1-9.
Crossref
Crossref
Sara Stigliani, Michela Croce, Fabio Morandi, Paola Scaruffi, Valentina Rigo, Barbara Carlini, Carla Manzitti, Anna Rita Gigliotti, Gian Paolo Tonini, Vito Pistoia, Silvano Ferrini & Maria Valeria Corrias. (2015)
Expression of
FOXP3
,
CD14
, and
ARG1
in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival
. BioMed Research International 2015, pages 1-10.
Crossref
Crossref